Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152

Glioblastomas (GBMs) are the most aggressive primary brain tumors in adult and remain a therapeutic challenge. Targeting key apoptosis regulators with the ultimate aim to restore apoptosis in tumor cells could be an interesting therapeutic strategy. The inhibitors of apoptosis proteins (IAPs) are re...

Descripción completa

Detalles Bibliográficos
Autores principales: Tchoghandjian, A, Soubéran, A, Tabouret, E, Colin, C, Denicolaï, E, Jiguet-Jiglaire, C, El-Battari, A, Villard, C, Baeza-Kallee, N, Figarella-Branger, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108315/
https://www.ncbi.nlm.nih.gov/pubmed/27490930
http://dx.doi.org/10.1038/cddis.2016.214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108315/
https://www.ncbi.nlm.nih.gov/pubmed/27490930
http://dx.doi.org/10.1038/cddis.2016.214

Ejemplares similares